By Kim Richters

Merck KGaA said late Tuesday that it has acquired Lonza Group AG's automated bioreactor sampling system, MAST.

The German pharmaceuticals-and-chemicals company didn't disclose financial terms of the deal.

"Today, biopharmaceutical companies are under immense pressure to get products to patients faster," Andrew Bulpin, head of process solutions at Merck KGaA's life-science business sector, said.

"The acquisition of the MAST platform adds fully automated sampling to our bioprocessing portfolio."

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

April 06, 2022 01:34 ET (05:34 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Merck KGAA.
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Merck KGAA.